HealthcareServices

Predictive Genetic Testing And Consumer Genomics Market Research: Growth Projections and Trends 2030

March 2, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the predictive genetic testing and consumer genomics market from 2026–2035 with trusted insights from The Business Research Company

Across 2026–2030, what is the expected market valuation path of the Predictive Genetic Testing And Consumer Genomics Market?

The predictive genetic testing and consumer genomics market has expanded rapidly in recent years. It is projected to increase from $9.07 billion in 2025 to $10.49 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 15.7%. The historical growth of this market can be attributed to enhanced consumer health awareness, greater accessibility to genetic testing, the rising availability of affordable sequencing technologies, an increasing interest in ancestry testing, and the development of digital health ecosystems.

The predictive genetic testing and consumer genomics market size is anticipated to experience rapid growth in the upcoming years. It is forecast to reach $18.61 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 15.4%. This expansion during the forecast period can be attributed to factors such as an increasing demand for personalized preventive healthcare, the rising adoption of pharmacogenomic testing, the expansion of consumer genomics platforms, growing integration with digital health apps, and increasing regulatory oversight on genetic data usage. Key trends for the forecast period include the increasing adoption of direct-to-consumer genetic testing, a rising use of digital health platforms, a growing demand for preventive health insights, the expansion of at-home sample collection kits, and an enhanced focus on data privacy and security.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25884&type=smp

Which Drivers Are Supporting The Rise Of The Predictive Genetic Testing And Consumer Genomics Market?

The increasing understanding of personalized medicine is anticipated to stimulate the expansion of the predictive genetic testing and consumer genomics market moving forward. Personalized medicine describes a medical approach that tailors treatment and prevention strategies based on an individual’s genetic profile, lifestyle, and environmental factors. Awareness of personalized medicine is growing because it enhances treatment effectiveness by aligning therapies with a patient’s unique biological characteristics. Predictive genetic testing and consumer genomics contribute to personalized medicine by identifying genetic risks and traits, which enables customized prevention, early diagnosis, and treatment strategies based on an individual’s genetic profile. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based professional membership organization, the Food and Drug Administration (FDA) approved 16 new personalized medicines in 2023, representing an increase from 6 in 2022. Consequently, the escalating awareness about personalized medicine is driving the growth of the predictive genetic testing and consumer genomics market.

What Leading Segments Are Studied In The Predictive Genetic Testing And Consumer Genomics Market?

The predictive genetic testing and consumer genomics market covered in this report is segmented –

1) By Testing Type: Diagnostic Testing, Predictive Testing, Pharmacogenomic Testing, Carrier Screening

2) By Technology: Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Microarray Technology, DNA Sequencing

3) By Service Type: Genetic Counseling Services, Sample Collection And Analysis, Data Interpretation And Reporting

4) By Application: Breast And Ovarian Cancer, Cardiovascular Screening, Diabetic Screening And Monitoring, Colon Cancer, Parkinsonism Or Alzheimer’s Disease, Urologic Screening Or Prostate Cancer Screening, Orthopedic And Musculoskeletal, Other Cancer Screening, Other Diseases

5) By End User: Healthcare Providers, Research Institutions, Diagnostic Laboratories, Consumers (Direct-to-Consumer Testing)

Subsegments:

1) By Diagnostic Testing: Cancer Diagnostic Testing, Neurological Disorder Testing, Rare Disease Diagnostics

2) By Predictive Testing: Cancer Risk Prediction, Cardiovascular Disease Risk, Neurodegenerative Disorder Risk

3) By Pharmacogenomic Testing: Adverse Drug Reaction Prediction, Psychiatric Medication Response, Dosage Optimization

4) By Carrier Screening: Cystic Fibrosis Carrier Screening, Sickle Cell Anemia Carrier Screening, Tay-Sachs Carrier Screening

Which Trends Are Guiding The Evolution Of The Predictive Genetic Testing And Consumer Genomics Market?

Leading companies within the predictive genetic testing and consumer genomics market are prioritizing technological innovations, specifically high-throughput and cost-efficient sequencing, to facilitate large-scale, accurate, and affordable genomic analysis. High-throughput and cost-efficient sequencing involves rapidly processing a vast quantity of genomes at reduced per-genome costs, making population-level testing viable. For instance, in February 2024, Ultima Genomics Inc., a U.S.-based sequencing company, unveiled its UG 100 sequencing system alongside the ppmSeq extreme-accuracy mode, delivering up to 6–8 billion reads per wafer, with dual-wafer runs attaining approximately 4.8 Tb and anticipated run times under 14 hours. Constructed with a wafer-based substrate and adaptable reagent cartridges, the system supports an industry-leading ~$100-genome roadmap, leveraging reagent costs of roughly $2,000 per wafer. The ppmSeq mode allows for Q60 SNV raw-read accuracy without requiring supplementary workflow steps. Leveraging its combination of low reagent costs, extensive automation, and AI-driven variant calling, the UG 100 is suited for diverse applications in consumer genomics, population screening, clinical WGS, pharmacogenomics, and large-scale research. Ultimately, the platform provides genomic data generation that is quicker, more scalable, and more economical than older NGS technologies.

Which Leading Companies Dominate The Predictive Genetic Testing And Consumer Genomics Market Share?

Major companies operating in the predictive genetic testing and consumer genomics market are Thermo Fisher Scientific Inc., Abbott Laboratories, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, QIAGEN N.V., Ancestry.com, Myriad Genetics Inc., ARUP Laboratories, BGI Genomics Co. Ltd., Invitae Corporation, 23andMe Inc., Helix Inc., Color Health Inc., Mapmygenome India Ltd., Reliance Life Sciences, Dante Labs Inc., EasyDNA, Gene by Gene Ltd., Nebula Genomics Inc., Pathway Genomics Corporation

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/predictive-genetic-testing-and-consumer-genomics-global-market-report

How Does The Predictive Genetic Testing And Consumer Genomics Market Perform Across Major Global Regions?

North America was the largest region in the predictive genetic testing and consumer genomics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the predictive genetic testing and consumer genomics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Predictive Genetic Testing And Consumer Genomics Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=25884&type=smp

Browse Through More Reports Similar to the Global Predictive Genetic Testing And Consumer Genomics Market 2026, By The Business Research Company

Genetic Testing Services Market Report 2026

https://www.thebusinessresearchcompany.com/report/genetic-testing-services-global-market-report

Direct To Consumer Dtc Genetic Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/direct-to-consumer-dtc-genetic-testing-global-market-report

Genetic Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/genetic-testing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795